ADA 2023: Discontinuing Metformin Tied to Worse Cardio-Renal, Survival Outcomes
Outcomes poor at eGFR less than 30 mL/min/1.73m2 irrespective of cardiovascular status
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.